全文获取类型
收费全文 | 1200篇 |
免费 | 180篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 58篇 |
妇产科学 | 17篇 |
基础医学 | 54篇 |
口腔科学 | 11篇 |
临床医学 | 156篇 |
内科学 | 273篇 |
皮肤病学 | 39篇 |
神经病学 | 85篇 |
特种医学 | 83篇 |
外科学 | 181篇 |
综合类 | 60篇 |
现状与发展 | 20篇 |
一般理论 | 1篇 |
预防医学 | 244篇 |
眼科学 | 26篇 |
药学 | 22篇 |
中国医学 | 2篇 |
肿瘤学 | 53篇 |
出版年
2024年 | 7篇 |
2023年 | 42篇 |
2021年 | 18篇 |
2020年 | 24篇 |
2019年 | 11篇 |
2018年 | 56篇 |
2017年 | 46篇 |
2016年 | 31篇 |
2015年 | 42篇 |
2014年 | 48篇 |
2013年 | 69篇 |
2012年 | 39篇 |
2011年 | 45篇 |
2010年 | 52篇 |
2009年 | 68篇 |
2008年 | 43篇 |
2007年 | 33篇 |
2006年 | 36篇 |
2005年 | 24篇 |
2004年 | 30篇 |
2003年 | 31篇 |
2002年 | 29篇 |
2001年 | 31篇 |
2000年 | 21篇 |
1999年 | 27篇 |
1998年 | 32篇 |
1997年 | 33篇 |
1996年 | 45篇 |
1995年 | 30篇 |
1994年 | 19篇 |
1993年 | 22篇 |
1992年 | 16篇 |
1991年 | 12篇 |
1990年 | 18篇 |
1989年 | 20篇 |
1988年 | 20篇 |
1987年 | 23篇 |
1986年 | 19篇 |
1985年 | 19篇 |
1984年 | 9篇 |
1983年 | 17篇 |
1982年 | 17篇 |
1981年 | 8篇 |
1980年 | 9篇 |
1979年 | 11篇 |
1978年 | 20篇 |
1977年 | 10篇 |
1976年 | 10篇 |
1975年 | 9篇 |
1971年 | 6篇 |
排序方式: 共有1397条查询结果,搜索用时 0 毫秒
31.
S. Yan J. Li S. Li B. Zhang S. Du P. Gordon‐Larsen L. Adair B. Popkin 《Obesity reviews》2012,13(9):810-821
China faces a major increase in cardiovascular disease, yet there is limited population‐based data on risk factors, particularly in children. Fasting blood samples, anthropometry and blood pressure were collected on 9,244 children and adults aged ≥7 years in late 2009 as part of the national China Health and Nutrition Survey. Prevalent overweight, elevated blood pressure, and cardiometabolic risk factors: glucose, HbA1c, triglycerides (TG), total cholesterol (TC), high‐ and low‐density lipoprotein cholesterol (HDL‐C and LDL‐C), and C‐reactive protein (CRP) are presented. We found that 11% of Chinese children and 30% of Chinese adults are overweight. Rates of diabetes, dyslipidaemia, hypertension and inflammation are high and increased with age and were associated with urbanization. Approximately 42% of children have at least one of the following: pre‐diabetes or diabetes, hypertension, high TC, LDL‐C, TG, and CRP and low HDL‐C, as do 70% men and 60% women aged 18–40 years and >90% of men and women ≥60 years. In sum, the HbA1c findings suggest that as many as 27.7 million Chinese children and 334 million Chinese adults may be pre‐diabetic or diabetic. The high prevalence in less urban areas and across all income levels suggests that cardiometabolic risk is pervasive across rural and urban China. 相似文献
32.
Carbonated soft drinks and other beverages make up an increasing percentage of energy intake, and there are rising public health concerns about the links between consumption of sugar-sweetened beverages and weight gain, obesity, and other cardiometabolic problems. In response, the food and beverage industry claims to be reformulating products, reducing package or portion sizes and introducing healthier options. Comparative analysis on various changes and their potential effects on public health are needed. We conduct a case study using the two largest and most influential producers of sweetened beverages, The Coca-Cola Company and PepsiCo Inc., who together control 34% of the global soft drink market, examining their product portfolios globally and in three critical markets (the United States, Brazil and China) from 2000 to 2010. On a global basis, total revenues and energy per capita sold increased, yet the average energy density (kJ 100 mL(-1) ) sold declined slightly, suggesting a shift to lower-calorie products. In the United States, both total energy per capita and average energy density of beverages sold decreased, while the opposite was true in the developing markets of Brazil and China, with total per capita energy increasing greatly in China and, to a lesser extent, in Brazil. 相似文献
33.
David Adlam BA BM BCh DPhil Nicholas Evans MB BCh Aneil Malhotra MA MB BCh Disha Midha BCom/BSc BM Felicity Rowley BSc BM BCh David Hutchings MB ChB Mirae Shin BM BCh Guy Mole BSc Alexander Stockenhuber Mark Lumb BM BCh Jonathan Wordsworth MA MB BCh Sophie Frantal MSc J. Colin Forfar MD PhD FRCP 《Catheterization and cardiovascular interventions》2012,80(4):539-545
Objectives : To investigate rates of and reasons for second and subsequent stent procedures in an unselected, “real‐world” population. Background : Repeat stenting is the primary difference reported in clinical trials of alternative revascularization strategies. The incidence, indication, and outcome for repeat stenting in contemporary practice outside the more selective populations of trials and registries has not been described. Method : All patients undergoing a first percutaneous coronary intervention (PCI) procedure with stenting from January 2001 to August 2009 (10,509) from a large UK tertiary referral and district general hospital were identified. Mortality and the incidence, timing, and indication for repeat revascularization in this population were investigated from patient records. Results : Of 10,509 patients undergoing a first PCI and stent implant 23.5% underwent repeat angiography of which 11.2% required repeat PCI and 2% coronary artery bypass grafting (median follow‐up of 3.8 years). A total of 1.3% went on to a third PCI. The commonest indication for repeat stenting was disease progression remote from the original stent (46%) and planned staged PCI (23%); 21% had a stent‐related indication. Functional assessment before repeat stenting was used in one‐third of stable patients. Mortality was 2.5% per annum. Conclusions : In contemporary practice, patients undergoing a first stenting procedure have a low subsequent mortality, and the substantial majority (86.4%) requires no further revascularization over a median 3.8 year follow‐up. For those who do require repeat stenting, this is most commonly at a site remote from the first stent. © 2012 Wiley Periodicals, Inc. 相似文献
34.
35.
36.
37.
Kirsi Murtomäki MD Tuomas Mertsalmi MD Elina Jaakkola MD PhD Elina Mäkinen MD PhD Reeta Levo RN Tanja Nojonen RN Mikael Eklund BM Simo Nuuttila BM Kari Lindholm RN Eero Pekkonen MD PhD Juho Joutsa MD PhD Tommi Noponen PhD Toni Ihalainen PhD Valtteri Kaasinen MD PhD Filip Scheperjans MD PhD 《Movement disorders》2022,37(6):1284-1289
38.
Meredith Achey BM Jason L. Aldred MD Noha Aljehani MD Bastiaan R. Bloem MD PhD Kevin M. Biglan MD MPH Piu Chan MD PhD Esther Cubo MD PhD E. Ray Dorsey MD MBA Christopher G. Goetz MD Mark Guttman MD Anhar Hassan MB BCh FRACP Suketu M. Khandhar MD Zoltan Mari MD Meredith Spindler MD Caroline M. Tanner MD PhD Pieter van den Haak MSc Richard Walker MD Jayne R. Wilkinson MD 《Movement disorders》2014,29(7):871-883
Travel distance, growing disability, and uneven distribution of doctors limit access to care for most Parkinson's disease (PD) patients worldwide. Telemedicine, the use of telecommunications technology to deliver care at a distance, can help overcome these barriers. In this report, we describe the past, present, and likely future applications of telemedicine to PD. Historically, telemedicine has relied on expensive equipment to connect single patients to a specialist in pilot programs in wealthy nations. As the cost of video conferencing has plummeted, these efforts have expanded in scale and scope, now reaching larger parts of the world and extending the focus from care to training of remote providers. Policy, especially limited reimbursement, currently hinders the growth and adoption of these new care models. As these policies change and technology advances and spreads, the following will likely develop: integrated care networks that connect patients to a wide range of providers; education programs that support patients and health care providers; and new research applications that include remote monitoring and remote visits. Together, these developments will enable more individuals with PD to connect to care, increase access to expertise for patients and providers, and allow more‐extensive, less‐expensive participation in research. © 2014 International Parkinson and Movement Disorder Society 相似文献
39.
40.
Brian C. Case MD Sant Kumar BA Charan Yerasi MD Brian J. Forrestal MBBS Anees Musallam MD Chava Chezar-Azerrad MD Nauman Khalid MD Evan Shlofmitz DO Yuefeng Chen MD PhD Jaffar M. Khan BM BCh PhD Lowell F. Satler MD Itsik Ben-Dor MD Hayder Hashim MD Nelson L. Bernardo MD Toby Rogers MD PhD Ron Waksman MD 《Catheterization and cardiovascular interventions》2021,98(3):572-577